Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bay 1002670
1. 1262108-14-4
2. Vilaprisan [inn]
3. Bay1002670
4. In59k53gi9
5. Bay-1002670
6. (8s,11r,13s,14s,17s)-17-hydroxy-13-methyl-11-(4-methylsulfonylphenyl)-17-(1,1,2,2,2-pentafluoroethyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
7. 19-norpregna-4,9-dien-3-one, 20,20,21,21,21-pentafluoro-17-hydroxy-11-(4-(methylsulfonyl)phenyl)-, (11beta,17alpha)-
8. 19-norpregna-4,9-dien-3-one, 20,20,21,21,21-pentafluoro-17-hydroxy-11-[4-(methylsulfonyl)phenyl]-, (11beta,17alpha)-
9. Unii-in59k53gi9
10. Bay 1002670
11. Vilaprisan [jan]
12. Vilaprisan [usan:inn]
13. Vilaprisan [usan]
14. Vilaprisan [who-dd]
15. Vilaprisan (jan/usan/inn)
16. Schembl2121854
17. Chembl3989936
18. Dtxsid201110777
19. Bcp24069
20. Db11971
21. 20,20,21,21,21-pentafluoro-17-hydroxy-11beta-(4-(methanesulfonyl)phenyl)-19-nor-17alpha-pregna-4,9-dien-3-one
22. Ac-30930
23. D11181
24. Q27280805
25. (8s,11r,13s,14s,17r)-17-hydroxy-13-methyl-11-(4-(methylsulfonyl)phenyl)-17-(perfluoroethyl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3h-cyclopenta[a]phenanthren-3-one
26. 19-norpregna-4,9-dien-3-one, 20,20,21,21,21-pentafluoro-17-hydroxy-11-(4-(methylsulfonyl)phenyl)-, (11.beta.,17.alpha.)-
27. 20,20,21,21,21-pentafluoro-17-hydroxy-11.beta.-(4-(methanesulfonyl)phenyl)-19-nor-17.alpha.-pregna-4,9-dien-3-one
28. Bay1002670; Bay-1002670; Bay 1002670; Bay-10-02670; Bay10-02670; Bay 10-02670
| Molecular Weight | 544.6 g/mol |
|---|---|
| Molecular Formula | C27H29F5O4S |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 544.17067139 g/mol |
| Monoisotopic Mass | 544.17067139 g/mol |
| Topological Polar Surface Area | 79.8 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 1140 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
28
PharmaCompass offers a list of Vilaprisan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vilaprisan manufacturer or Vilaprisan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vilaprisan manufacturer or Vilaprisan supplier.
PharmaCompass also assists you with knowing the Vilaprisan API Price utilized in the formulation of products. Vilaprisan API Price is not always fixed or binding as the Vilaprisan Price is obtained through a variety of data sources. The Vilaprisan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vilaprisan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vilaprisan, including repackagers and relabelers. The FDA regulates Vilaprisan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vilaprisan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vilaprisan supplier is an individual or a company that provides Vilaprisan active pharmaceutical ingredient (API) or Vilaprisan finished formulations upon request. The Vilaprisan suppliers may include Vilaprisan API manufacturers, exporters, distributors and traders.
Vilaprisan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vilaprisan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vilaprisan GMP manufacturer or Vilaprisan GMP API supplier for your needs.
A Vilaprisan CoA (Certificate of Analysis) is a formal document that attests to Vilaprisan's compliance with Vilaprisan specifications and serves as a tool for batch-level quality control.
Vilaprisan CoA mostly includes findings from lab analyses of a specific batch. For each Vilaprisan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vilaprisan may be tested according to a variety of international standards, such as European Pharmacopoeia (Vilaprisan EP), Vilaprisan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vilaprisan USP).
